上海华源药业(宁夏)沙赛制药有限公司

Manufacturer / marketing-authorisation holder

上海华源药业(宁夏)沙赛制药有限公司 — 25 products across 1 markets, 1 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

上海华源药业(宁夏)沙赛制药有限公司 — 25 productos en 1 mercados, 1 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

上海华源药业(宁夏)沙赛制药有限公司 —— 共 25 个产品,覆盖 1 个市场、1 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

25 products · 1 markets · 1 brand names

25 productos · 1 mercados · 1 marcas

25 个产品 · 1 个市场 · 1 个品牌名

Products by country

CN (25 records)

Source: code.nhsa.gov.cn

BrandActive ingredient(s)Form
—兰索拉唑injection
—盐酸帕洛诺司琼injection
—盐酸帕洛诺司琼injection
—盐酸帕洛诺司琼injection
—苦参素injection
—苦参素injection
—氨基酸injection
—单硝酸异山梨酯injection
—单硝酸异山梨酯injection
—生长抑素injection
—生长抑素injection
—生长抑素injection
—生长抑素injection
—生长抑素injection
—生长抑素injection
—生长抑素injection
—生长抑素injection
—氟康唑injection
—更昔洛韦injection
—更昔洛韦injection
—胸腺五肽injection
—胸腺五肽injection
—胸腺五肽injection
—盐酸氨溴索injection
沙赛博通葛根素injection
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.